Aerivio Spiromax 50 microgram/500 microgram inhalation powder
Last Updated on eMC 15-Jun-2017 View document | Teva Pharma B.V. Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 15-Jun-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
Updated on 17-Mar-2017 and displayed until 15-Jun-2017
Reasons for adding or updating:
- Change to section 2 - interactions with other medicines, food or drink
Updated on 09-Mar-2017 and displayed until 17-Mar-2017
Reasons for adding or updating:
- New PIL for new product
Teva Pharma B.V.
Field House, Station Approach, Harlow, Essex, CM20 2FB
+44(0)207 5407117
+44(0)207 5407349
0800 590 502
+44(0)1977 628500
0800 590 502
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue